117 related articles for article (PubMed ID: 6435814)
1. Activity of ciprofloxacin against genital tract pathogens.
Hart CA; How SJ; Hobson D
Br J Vener Dis; 1984 Oct; 60(5):316-8. PubMed ID: 6435814
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of A-56619 (difloxacin), A-56620, and other new quinolone antimicrobial agents against genital pathogens.
Liebowitz LD; Saunders J; Fehler G; Ballard RC; Koornhof HJ
Antimicrob Agents Chemother; 1986 Dec; 30(6):948-50. PubMed ID: 3101590
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of the two new 4-quinolones A56619 and A56620 against Neisseria gonorrhoeae, Chlamydia trachomatis, Mycoplasma hominis, Ureaplasma urealyticum and Gardnerella vaginalis.
Tjiam KH; Wagenvoort JH; van Klingeren B; Piot P; Stolz E; Michel MF
Eur J Clin Microbiol; 1986 Oct; 5(5):498-501. PubMed ID: 3096726
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ciprofloxacin and norfloxacin against Gardnerella vaginalis.
Machka K
Eur J Clin Microbiol; 1984 Aug; 3(4):374. PubMed ID: 6237906
[No Abstract] [Full Text] [Related]
5. In vitro activity of sparfloxacin and other antimicrobial agents against genital pathogens.
Lefèvre JC; Bauriaud R; Gaubert E; Escaffre MC; Lareng MB
Chemotherapy; 1992; 38(5):303-7. PubMed ID: 1337506
[TBL] [Abstract][Full Text] [Related]
6. The comparative in-vitro activity of pefloxacin.
King A; Phillips I
J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-10. PubMed ID: 2940213
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of difloxacin hydrochloride (A-56619), A-56620, and cefixime (CL 284,635; FK 027) against selected genital pathogens.
Bowie WR; Shaw CE; Chan DG; Boyd J; Black WA
Antimicrob Agents Chemother; 1986 Oct; 30(4):590-3. PubMed ID: 3098163
[TBL] [Abstract][Full Text] [Related]
8. Activities of new quinoline derivatives against genital pathogens.
Aznar J; Caballero MC; Lozano MC; de Miguel C; Palomares JC; Perea EJ
Antimicrob Agents Chemother; 1985 Jan; 27(1):76-8. PubMed ID: 3920959
[TBL] [Abstract][Full Text] [Related]
9. Relative susceptibilities of Gardnerella vaginalis (Haemophilus vaginalis), Neisseria gonorrhoeae, and Bacteroides fragilis to Metronidazole and its two major metabolites.
Ralph ED; Amatnieks YE
Sex Transm Dis; 1980; 7(4):157-60. PubMed ID: 6779387
[TBL] [Abstract][Full Text] [Related]
10. In-vitro activity of azithromycin, erythromycin, ciprofloxacin and norfloxacin against Neisseria gonorrhoeae, Haemophilus ducreyi, and Chlamydia trachomatis.
Slaney L; Chubb H; Ronald A; Brunham R
J Antimicrob Chemother; 1990 Jan; 25 Suppl A():1-5. PubMed ID: 2154426
[TBL] [Abstract][Full Text] [Related]
11. In vitro antimicrobial activity of rosoxacin against Neisseria gonorrhoeae, Chlamydia trachomatis, and Ureaplasma urealyticum.
Dobson RA; O'Connor JR; Poulin SA; Kundsin RB; Smith TF; Came PE
Antimicrob Agents Chemother; 1980 Nov; 18(5):738-40. PubMed ID: 6778385
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of seventeen antimicrobial agents against Gardnerella vaginalis.
Shanker S; Toohey M; Munro R
Eur J Clin Microbiol; 1982 Oct; 1(5):298-300. PubMed ID: 6223813
[TBL] [Abstract][Full Text] [Related]
13. The activity of ciprofloxacin and other 4-quinolones against Chlamydia trachomatis and Mycoplasmas in vitro.
Ridgway GL; Mumtaz G; Gabriel FG; Oriel JD
Eur J Clin Microbiol; 1984 Aug; 3(4):344-6. PubMed ID: 6237903
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of 5 new quinolones against Gardnerella vaginalis].
Lefevre JC; Gaubert E; Lareng MB
Pathol Biol (Paris); 1989 May; 37(5):394-6. PubMed ID: 2550875
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity of Haemophilus vaginalis (Corynebacterium vaginale) to oleandomycin and spectinomycin.
Virtanen S
Pathol Microbiol (Basel); 1975; 42(1):36-41. PubMed ID: 125402
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of ciprofloxacin against Chlamydia trachomatis and Ureaplasma urealyticum.
Rumpianesi F; Sambri V; Bertini S; Tamba I; Cevenini R
Chemioterapia; 1984 Jun; 3(3):173-4. PubMed ID: 6529772
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of tosufloxacin (A-61827; T-3262) against selected genital pathogens.
Segreti J; Hirsch DJ; Harris AA; Kapell KS; Orbach H; Kessler HA
Antimicrob Agents Chemother; 1990 Jun; 34(6):971-3. PubMed ID: 2118330
[TBL] [Abstract][Full Text] [Related]
18. Activity of thiamphenicol against Chlamydia trachomatis and Neisseria gonorrhoeae.
Ridgway GL; Felmingham D; Mumtaz G; O'Hare M
Sex Transm Dis; 1984; 11(4 Suppl):432-4. PubMed ID: 6441286
[TBL] [Abstract][Full Text] [Related]
19. In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae.
Peeters M; Van Dyck E; Piot P
Antimicrob Agents Chemother; 1984 Oct; 26(4):608-9. PubMed ID: 6240224
[TBL] [Abstract][Full Text] [Related]
20. In Vitro Activity of Sitafloxacin and Additional Newer Generation Fluoroquinolones Against Ciprofloxacin-Resistant Neisseria gonorrhoeae Isolates.
Hamasuna R; Ohnishi M; Matsumoto M; Okumura R; Unemo M; Matsumoto T
Microb Drug Resist; 2018; 24(1):30-34. PubMed ID: 28581359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
